( 1 4 ) | Income Taxes |
| April 30, 2017 | April 30, 2016 | |||||||
| (in thousands) | ||||||||
| Domestic | $ | (9,805 | ) | $ | (14,223 | ) | ||
| Foreign | (379 | ) | (535 | ) | ||||
| Total loss before income taxes | $ | (10,184 | ) | $ | (14,758 | ) | ||
| April 30, 2017 | April 30, 2016 | |||||||
| Computed expected tax benefit | -34.0 | % | -34.0 | % | ||||
| Increase(reduction) in income taxes resulting from: | ||||||||
| State income taxes, net of federal benefit | 2.3 | % | 6.0 | % | ||||
| Federal research and development tax credits | -1.7 | % | -3.0 | % | ||||
| Foreign rate differential | 0.3 | % | 1.0 | % | ||||
| Other non-deductible expenses | 0.1 | % | 5.0 | % | ||||
| Proceeds of sale of New Jersey tax benefits | -6.9 | % | -11.0 | % | ||||
| Other | 11.7 | % | 13.0 | % | ||||
| Increase in valuation allowance | 25.9 | % | 12.0 | % | ||||
| Income tax benefit | 2.3 | % | -11.0 | % | ||||
| April 30, 2017 | April 30, 2016 | |||||||
| (in thousands) | ||||||||
| Deferred tax assets: | ||||||||
| Federal net operating loss carryforwards | $ | 44,355 | $ | 40,540 | ||||
| Foreign net operating loss carryforwards | 3,761 | 4,393 | ||||||
| State operating loss carryforwards | 1,281 | 1,375 | ||||||
| Federal and New Jersey research and development tax credits | 2,996 | 2,708 | ||||||
| Stock compensation | 1,096 | 732 | ||||||
| Unrealized foreign exchange loss | 17 | 536 | ||||||
| Accrued expenses | 576 | 1,324 | ||||||
| Other | 627 | 945 | ||||||
| Net deferred tax assets before valuation allowance | 54,709 | 52,553 | ||||||
| Valuation allowance | (54,709 | ) | (52,553 | ) | ||||
| Net deferred tax assets | $ | - | $ | - | ||||